Cerebricon Services:
 
 

Cerebricon Ltd.

A fully private provider of high quality and cost effective pre-clinical contract research services to the pharmaceutical industry. Cerebricon is at the forefront in terms of delivering timely and cost-effective solutions for proof of concept and proof of principle studies. 

Fully professional and customized contract management combined with proprietal in vitro and in vivo laboratories and a dedicated scientific staff with over 150 years of cumulative experience.

Broad Experience Base
in the
Preclinical Testing of Pharmaceuticals
for
CNS Diseases

  • Fully GLP compliant - internal and external Quality Assurance Programs
  • Proprietal in vivo, in vitro, behavioral and histological labs
  • Breeding and holding facilities
  • All models validated and performed in-house by our own full-time staff of scientists and technicians
  • Dedicated MRI
  • Interactive and flexible Cerebricon - Client, design reporting and study review structure

News:

4.4.2008
Kuopio, Finland; London, UK: Cerebricon and Medestea publish pre-clinical efficacy data for IAC in a model of stroke in the rat

26.10.2007
Kuopio, Finland; London, UK; Stockholm Sweden: Cerebricon Ltd. and Pronexus Analytical AB Sign Exclusive Agreement in the Areas of Marketing and Scientific Collaboration

26.10.2007
Kuopio, Finland; London, UK: Cerebricon Ltd. Obtains 3rd Party Transgenic SOD1 License for the Study of ALS

3.8.2007
Kuopio; London: Cerebricon to Exhibit at the SFN 37th Annual Meeting in San Diego

31.7.2007
Kuopio; London: Cerebricon increases focus on translational aspects of preclinical drug development: Imaging/MRI/MRS